{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-26-000349","form_type":"8-K","ticker":"ADCT","cik":"0001771910","company_name":"ADC Therapeutics SA","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.127422+00:00","generated_at":"2026-05-16T10:54:55.924472+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ADC Therapeutics posts updated corporate presentation with no material new disclosures","bullets":["ADC Therapeutics made available an updated corporate presentation dated January 2026 via 8-K filing.","The presentation excerpt contains only forward-looking statements boilerplate; no specific financial data or events.","No changes to guidance, pipeline status, or leadership were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-000349","json":"https://secwatch.observer/filing/0000950103-26-000349.json","markdown":"https://secwatch.observer/filing/0000950103-26-000349.md","text":"https://secwatch.observer/filing/0000950103-26-000349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/0000950103-26-000349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/dp239825_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:54:55.924472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}